2026 Q1 -tulosraportti
Vain PDF
101 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 4 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenWhile we wait for Weeco Astrum 10/10 to be released by German customs, I check every day whether the various pharmacies have restocked their shelves with Weeco Astrum 10/10, so I can put the yellow bar on, but we are not there yet. However, a pharmacy in Bonn has received the oil in stock again, by buying internally. Everything below I have deduced based on the research I have conducted since May 13. (It has not been verified by anyone from Stenocare) It's an ill wind that blows nobody any good, because I have wondered why the pharmacies that have permission to do so have bought Weeco Astrum 10/10 internally, after Weeco Pharma's stock has been completely emptied for about 14 days now. I have also noticed that there has been a pharmacy, happyhanf apotek near Fredsege, in Hamburg, which at no point has been sold out. Even though this pharmacy has a large storage capacity, they must comply with German regulations regarding medicine stock, and therefore I dug a little into it. I found out that there is an exception to the rule, and that is that Weeco Pharma is allowed to place a satellite warehouse in a pharmacy's back room, if this meets German regulations. Which I guess Weeco Pharma has done. We don't know when they made the above decision, but if it is to make sense, it must have been after July 10 that they made this decision. But that it should be in Hamburg, and not in the Dusseldoft region, I found strange, because we know that doctors have started prescribing Weeco Astrum 10/10 in large numbers, and Hamburg is 400 km away? Due to this great distance from Dusseldorf, I thought there must be a reason for this madness, and therefore I started to dig a little. Based on the knowledge I have acquired about German regulations, I thought that there can only be one reason why they have placed a satellite warehouse there, and that must be because the majority of people in Hamburg traditionally are larger consumers of vapes and smoke medical cannabis than medical oils, and therefore Weeco Pharma has taken a chance and established a satellite warehouse at this pharmacy in Hamburg, so there will be enough oil for the new users who get a prescription Weeco Astrum 10/10. It is a very expensive chance that Weeco Pharma has taken, if it turns out that they have made a mistake, and therefore that must be the reason why they have placed a satellite warehouse in Hamburg. (Just like the pharmacies, Weeco Pharma is subject to the same rules, and they are also not allowed to just buy in and have Weeco Astrum 10/10 in stock; this must also match the prescriptions being issued) When I have deduced the above, it is because, in addition to the premises having to be approved by the authorities, Weeco Pharma is also not allowed to use this as a reserve stock and sell to their other customers from this stock, but the pharmacy is allowed to sell internally to other pharmacies that have permission to do so. This should be a very cumbersome process, and the profit less than when pharmacies sell directly to customers. The latter is actually the reason why I started to wonder, when it is so cumbersome to have a satellite warehouse as described, there must be a carrot big enough for them to take on the difficulties. Logically, it must be because the pharmacies know who they sell to and how much, and therefore traditionally there must have been more users in Hamburg who bought flowers than oil. The pharmacist has full control over this, so when the subsidy for flower medicine was removed, the pharmacist could see the writing on the wall, that some of these customers would get prescriptions for oil, and then it is good to have so much in stock that they can supply these customers, because you don't make money if you don't have the products on the shelves. It is only if there will be extraordinary sales of oils in Hamburg, as the private flower stock runs out, and if there will be media writing about it, that we will find out if what I have deduced is correct, because I cannot see the number of oils they have in stock, only whether it is in stock or sold out.
- ·1 päivä sittenI accidentally stumbled upon an article from today. Where Streeck from CDU, joins forces with Nina W, Minister of Health, to regulate cannabis flowers much more strictly than they are today. It has been a huge thorn in both their sides from the very beginning that cannabis flowers have been legalized at all. Both believe that it is okay for cannabis oil to be legalized, and the subsidy should remain as it is, because it cannot be smoked or vaped. Even if it is not intended by the politicians, it must give even more tailwind to the oils. When they get their way, that's how it looks right now. And then I think I have found out what is the reason why a stopper has been put in the German customs system, and that there, little by little, a shortage of cannabis oil has begun to emerge. Large Canadian companies producing cannabis flowers have recently sent large batches to Germany. It is much more complicated for customs officers to approve cannabis flowers than a pre-manufactured oil, and therefore it takes longer to release these batches. I cross my fingers that customs will let the oil move into the fast lane, so that it can be released quickly and be on the shelves when customers need it. Unfortunately, I cannot find the article again, I accidentally closed the system. If I find it, I will put it below. Have a good weekend Streeck calls for revisions to the cannabis law: four points at the committee meeting https://www.hanf-magazin.com/politik/deutschland/streeck-fordert-korrekturen-am-cannabisgesetz-vier-baustellen-vor-der-ausschussrunde/The article about cannabis flowers to Germany from Canada https://stratcann.com/news/canopy-growths-kincardine-facility-secures-eu-gmp-recertification/
- ·2 päivää sittenStock status Status quo Yesterday it was 14 days since we discovered that the first pharmacies had sold out of Weeco Astrum 10/10, and it did not return to stock within 24 hours, as we have seen it happen before. I have tried to find out where the bottleneck is in the German system, because I have ruled out that Stenocare cannot keep up with production. Since the exact reasons are to be found in closed forums with the authorities, where I do not have access. I would like to snoop around a bit, but I don't have access. So I'm guessing that the bottleneck must be with German customs, because I have noticed, and shared here on Nordnet Social, that it seems that other brands are also sold out, as well as several different cannabis flowers, which have also not returned to the shelves. Therefore, I think that the German customs officers are working tirelessly at the moment, to remove this backlog of medical cannabis, which is just waiting to be released, to enter Germany. All the different producers who have felt this sudden demand have naturally gotten their act together, and sent their products to Germany, to cover the enormous demand that suddenly arose because the subsidy fund for flower medicine slammed shut with a huge bang. We have seen the first wave of patients, who normally would have received prescriptions for flower medicine, received a prescription for cannabis oils instead. I hope that next week, the batch of Weeco Astrum10/10 that is waiting to be released will actually be released and come onto the shelves, so that the oil is ready when the next wave comes and needs cannabis oil. The above is only speculation on my part.
- ·3 päivää sitten · MuokattuStock status Everything is status quo, so we can conclude that it has not yet been possible to get the oil into Germany. But as long as Germany is not completely dry, people can get hold of the oil when they get a prescription. The following is on my bill. I'm crossing my fingers that Weeco Pharma will manage to get the oil into Germany before the people who have hoarded a small stock of flower medicine privately run out. The people who hoarded this summer have been able to buy 100 grams per month. Around 200 grams in total. How long will it take them to smoke/vape 200 grams of cannabis 2-3 months? As these stocks run out, they will go to their doctor to get a prescription for an alternative cannabis medicine to the flower medicine. Weeco Astrum 10/10 is not affected by a 6-month quarantine, and the product has retained 100% reimbursement, and therefore doctors can calmly (the feared Regress system) prescribe Weeco Astrum 10/10 to patients where doctors assess that they should have a prescription for Weeco Astrum 10/10. If my little unscientific calculation is correct, Weeco Pharma has a couple of months to run on, so I guess they will make it. It says approximately in the middle of the article and under the heading How exactly is cannabis prescribed? https://www.aerzteblatt.de/archiv/medizinisches-cannabis-die-wichtigsten-aenderungen-8947932a-bc22-401b-a928-ee432de6bc59I just have an addition to the above. It occurred to me that I have read somewhere that it was also changed that people now have to meet with their general practitioner to get a prescription for medical cannabis. Telemedicine is forbidden (if I have understood it correctly, it is a complicated topic) A maximum of (at most) 3 months may pass before a doctor sees their patient with a chronic illness, which again means that the doctor may at most prescribe a prescription for medical cannabis that lasts for 3 months. Previously, they could prescribe a prescription for Weeco Astrum 10/10 2 bottles of 30 ml. and people typically bought 2 bottles at a time. They can no longer do that, when one bottle typically lasts 2-3 months. https://www.hausaerztlichepraxis.digital/praxis/medikamente-fuer-mehrere-monate-auf-rezept-moeglich-127970.html
- ·12.8.stock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.Today's figures increase in number of trades 612% the price 0.932 kr. and the price has increased by 3.72%.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
101 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenWhile we wait for Weeco Astrum 10/10 to be released by German customs, I check every day whether the various pharmacies have restocked their shelves with Weeco Astrum 10/10, so I can put the yellow bar on, but we are not there yet. However, a pharmacy in Bonn has received the oil in stock again, by buying internally. Everything below I have deduced based on the research I have conducted since May 13. (It has not been verified by anyone from Stenocare) It's an ill wind that blows nobody any good, because I have wondered why the pharmacies that have permission to do so have bought Weeco Astrum 10/10 internally, after Weeco Pharma's stock has been completely emptied for about 14 days now. I have also noticed that there has been a pharmacy, happyhanf apotek near Fredsege, in Hamburg, which at no point has been sold out. Even though this pharmacy has a large storage capacity, they must comply with German regulations regarding medicine stock, and therefore I dug a little into it. I found out that there is an exception to the rule, and that is that Weeco Pharma is allowed to place a satellite warehouse in a pharmacy's back room, if this meets German regulations. Which I guess Weeco Pharma has done. We don't know when they made the above decision, but if it is to make sense, it must have been after July 10 that they made this decision. But that it should be in Hamburg, and not in the Dusseldoft region, I found strange, because we know that doctors have started prescribing Weeco Astrum 10/10 in large numbers, and Hamburg is 400 km away? Due to this great distance from Dusseldorf, I thought there must be a reason for this madness, and therefore I started to dig a little. Based on the knowledge I have acquired about German regulations, I thought that there can only be one reason why they have placed a satellite warehouse there, and that must be because the majority of people in Hamburg traditionally are larger consumers of vapes and smoke medical cannabis than medical oils, and therefore Weeco Pharma has taken a chance and established a satellite warehouse at this pharmacy in Hamburg, so there will be enough oil for the new users who get a prescription Weeco Astrum 10/10. It is a very expensive chance that Weeco Pharma has taken, if it turns out that they have made a mistake, and therefore that must be the reason why they have placed a satellite warehouse in Hamburg. (Just like the pharmacies, Weeco Pharma is subject to the same rules, and they are also not allowed to just buy in and have Weeco Astrum 10/10 in stock; this must also match the prescriptions being issued) When I have deduced the above, it is because, in addition to the premises having to be approved by the authorities, Weeco Pharma is also not allowed to use this as a reserve stock and sell to their other customers from this stock, but the pharmacy is allowed to sell internally to other pharmacies that have permission to do so. This should be a very cumbersome process, and the profit less than when pharmacies sell directly to customers. The latter is actually the reason why I started to wonder, when it is so cumbersome to have a satellite warehouse as described, there must be a carrot big enough for them to take on the difficulties. Logically, it must be because the pharmacies know who they sell to and how much, and therefore traditionally there must have been more users in Hamburg who bought flowers than oil. The pharmacist has full control over this, so when the subsidy for flower medicine was removed, the pharmacist could see the writing on the wall, that some of these customers would get prescriptions for oil, and then it is good to have so much in stock that they can supply these customers, because you don't make money if you don't have the products on the shelves. It is only if there will be extraordinary sales of oils in Hamburg, as the private flower stock runs out, and if there will be media writing about it, that we will find out if what I have deduced is correct, because I cannot see the number of oils they have in stock, only whether it is in stock or sold out.
- ·1 päivä sittenI accidentally stumbled upon an article from today. Where Streeck from CDU, joins forces with Nina W, Minister of Health, to regulate cannabis flowers much more strictly than they are today. It has been a huge thorn in both their sides from the very beginning that cannabis flowers have been legalized at all. Both believe that it is okay for cannabis oil to be legalized, and the subsidy should remain as it is, because it cannot be smoked or vaped. Even if it is not intended by the politicians, it must give even more tailwind to the oils. When they get their way, that's how it looks right now. And then I think I have found out what is the reason why a stopper has been put in the German customs system, and that there, little by little, a shortage of cannabis oil has begun to emerge. Large Canadian companies producing cannabis flowers have recently sent large batches to Germany. It is much more complicated for customs officers to approve cannabis flowers than a pre-manufactured oil, and therefore it takes longer to release these batches. I cross my fingers that customs will let the oil move into the fast lane, so that it can be released quickly and be on the shelves when customers need it. Unfortunately, I cannot find the article again, I accidentally closed the system. If I find it, I will put it below. Have a good weekend Streeck calls for revisions to the cannabis law: four points at the committee meeting https://www.hanf-magazin.com/politik/deutschland/streeck-fordert-korrekturen-am-cannabisgesetz-vier-baustellen-vor-der-ausschussrunde/The article about cannabis flowers to Germany from Canada https://stratcann.com/news/canopy-growths-kincardine-facility-secures-eu-gmp-recertification/
- ·2 päivää sittenStock status Status quo Yesterday it was 14 days since we discovered that the first pharmacies had sold out of Weeco Astrum 10/10, and it did not return to stock within 24 hours, as we have seen it happen before. I have tried to find out where the bottleneck is in the German system, because I have ruled out that Stenocare cannot keep up with production. Since the exact reasons are to be found in closed forums with the authorities, where I do not have access. I would like to snoop around a bit, but I don't have access. So I'm guessing that the bottleneck must be with German customs, because I have noticed, and shared here on Nordnet Social, that it seems that other brands are also sold out, as well as several different cannabis flowers, which have also not returned to the shelves. Therefore, I think that the German customs officers are working tirelessly at the moment, to remove this backlog of medical cannabis, which is just waiting to be released, to enter Germany. All the different producers who have felt this sudden demand have naturally gotten their act together, and sent their products to Germany, to cover the enormous demand that suddenly arose because the subsidy fund for flower medicine slammed shut with a huge bang. We have seen the first wave of patients, who normally would have received prescriptions for flower medicine, received a prescription for cannabis oils instead. I hope that next week, the batch of Weeco Astrum10/10 that is waiting to be released will actually be released and come onto the shelves, so that the oil is ready when the next wave comes and needs cannabis oil. The above is only speculation on my part.
- ·3 päivää sitten · MuokattuStock status Everything is status quo, so we can conclude that it has not yet been possible to get the oil into Germany. But as long as Germany is not completely dry, people can get hold of the oil when they get a prescription. The following is on my bill. I'm crossing my fingers that Weeco Pharma will manage to get the oil into Germany before the people who have hoarded a small stock of flower medicine privately run out. The people who hoarded this summer have been able to buy 100 grams per month. Around 200 grams in total. How long will it take them to smoke/vape 200 grams of cannabis 2-3 months? As these stocks run out, they will go to their doctor to get a prescription for an alternative cannabis medicine to the flower medicine. Weeco Astrum 10/10 is not affected by a 6-month quarantine, and the product has retained 100% reimbursement, and therefore doctors can calmly (the feared Regress system) prescribe Weeco Astrum 10/10 to patients where doctors assess that they should have a prescription for Weeco Astrum 10/10. If my little unscientific calculation is correct, Weeco Pharma has a couple of months to run on, so I guess they will make it. It says approximately in the middle of the article and under the heading How exactly is cannabis prescribed? https://www.aerzteblatt.de/archiv/medizinisches-cannabis-die-wichtigsten-aenderungen-8947932a-bc22-401b-a928-ee432de6bc59I just have an addition to the above. It occurred to me that I have read somewhere that it was also changed that people now have to meet with their general practitioner to get a prescription for medical cannabis. Telemedicine is forbidden (if I have understood it correctly, it is a complicated topic) A maximum of (at most) 3 months may pass before a doctor sees their patient with a chronic illness, which again means that the doctor may at most prescribe a prescription for medical cannabis that lasts for 3 months. Previously, they could prescribe a prescription for Weeco Astrum 10/10 2 bottles of 30 ml. and people typically bought 2 bottles at a time. They can no longer do that, when one bottle typically lasts 2-3 months. https://www.hausaerztlichepraxis.digital/praxis/medikamente-fuer-mehrere-monate-auf-rezept-moeglich-127970.html
- ·12.8.stock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.Today's figures increase in number of trades 612% the price 0.932 kr. and the price has increased by 3.72%.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 4 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
101 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 4 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenWhile we wait for Weeco Astrum 10/10 to be released by German customs, I check every day whether the various pharmacies have restocked their shelves with Weeco Astrum 10/10, so I can put the yellow bar on, but we are not there yet. However, a pharmacy in Bonn has received the oil in stock again, by buying internally. Everything below I have deduced based on the research I have conducted since May 13. (It has not been verified by anyone from Stenocare) It's an ill wind that blows nobody any good, because I have wondered why the pharmacies that have permission to do so have bought Weeco Astrum 10/10 internally, after Weeco Pharma's stock has been completely emptied for about 14 days now. I have also noticed that there has been a pharmacy, happyhanf apotek near Fredsege, in Hamburg, which at no point has been sold out. Even though this pharmacy has a large storage capacity, they must comply with German regulations regarding medicine stock, and therefore I dug a little into it. I found out that there is an exception to the rule, and that is that Weeco Pharma is allowed to place a satellite warehouse in a pharmacy's back room, if this meets German regulations. Which I guess Weeco Pharma has done. We don't know when they made the above decision, but if it is to make sense, it must have been after July 10 that they made this decision. But that it should be in Hamburg, and not in the Dusseldoft region, I found strange, because we know that doctors have started prescribing Weeco Astrum 10/10 in large numbers, and Hamburg is 400 km away? Due to this great distance from Dusseldorf, I thought there must be a reason for this madness, and therefore I started to dig a little. Based on the knowledge I have acquired about German regulations, I thought that there can only be one reason why they have placed a satellite warehouse there, and that must be because the majority of people in Hamburg traditionally are larger consumers of vapes and smoke medical cannabis than medical oils, and therefore Weeco Pharma has taken a chance and established a satellite warehouse at this pharmacy in Hamburg, so there will be enough oil for the new users who get a prescription Weeco Astrum 10/10. It is a very expensive chance that Weeco Pharma has taken, if it turns out that they have made a mistake, and therefore that must be the reason why they have placed a satellite warehouse in Hamburg. (Just like the pharmacies, Weeco Pharma is subject to the same rules, and they are also not allowed to just buy in and have Weeco Astrum 10/10 in stock; this must also match the prescriptions being issued) When I have deduced the above, it is because, in addition to the premises having to be approved by the authorities, Weeco Pharma is also not allowed to use this as a reserve stock and sell to their other customers from this stock, but the pharmacy is allowed to sell internally to other pharmacies that have permission to do so. This should be a very cumbersome process, and the profit less than when pharmacies sell directly to customers. The latter is actually the reason why I started to wonder, when it is so cumbersome to have a satellite warehouse as described, there must be a carrot big enough for them to take on the difficulties. Logically, it must be because the pharmacies know who they sell to and how much, and therefore traditionally there must have been more users in Hamburg who bought flowers than oil. The pharmacist has full control over this, so when the subsidy for flower medicine was removed, the pharmacist could see the writing on the wall, that some of these customers would get prescriptions for oil, and then it is good to have so much in stock that they can supply these customers, because you don't make money if you don't have the products on the shelves. It is only if there will be extraordinary sales of oils in Hamburg, as the private flower stock runs out, and if there will be media writing about it, that we will find out if what I have deduced is correct, because I cannot see the number of oils they have in stock, only whether it is in stock or sold out.
- ·1 päivä sittenI accidentally stumbled upon an article from today. Where Streeck from CDU, joins forces with Nina W, Minister of Health, to regulate cannabis flowers much more strictly than they are today. It has been a huge thorn in both their sides from the very beginning that cannabis flowers have been legalized at all. Both believe that it is okay for cannabis oil to be legalized, and the subsidy should remain as it is, because it cannot be smoked or vaped. Even if it is not intended by the politicians, it must give even more tailwind to the oils. When they get their way, that's how it looks right now. And then I think I have found out what is the reason why a stopper has been put in the German customs system, and that there, little by little, a shortage of cannabis oil has begun to emerge. Large Canadian companies producing cannabis flowers have recently sent large batches to Germany. It is much more complicated for customs officers to approve cannabis flowers than a pre-manufactured oil, and therefore it takes longer to release these batches. I cross my fingers that customs will let the oil move into the fast lane, so that it can be released quickly and be on the shelves when customers need it. Unfortunately, I cannot find the article again, I accidentally closed the system. If I find it, I will put it below. Have a good weekend Streeck calls for revisions to the cannabis law: four points at the committee meeting https://www.hanf-magazin.com/politik/deutschland/streeck-fordert-korrekturen-am-cannabisgesetz-vier-baustellen-vor-der-ausschussrunde/The article about cannabis flowers to Germany from Canada https://stratcann.com/news/canopy-growths-kincardine-facility-secures-eu-gmp-recertification/
- ·2 päivää sittenStock status Status quo Yesterday it was 14 days since we discovered that the first pharmacies had sold out of Weeco Astrum 10/10, and it did not return to stock within 24 hours, as we have seen it happen before. I have tried to find out where the bottleneck is in the German system, because I have ruled out that Stenocare cannot keep up with production. Since the exact reasons are to be found in closed forums with the authorities, where I do not have access. I would like to snoop around a bit, but I don't have access. So I'm guessing that the bottleneck must be with German customs, because I have noticed, and shared here on Nordnet Social, that it seems that other brands are also sold out, as well as several different cannabis flowers, which have also not returned to the shelves. Therefore, I think that the German customs officers are working tirelessly at the moment, to remove this backlog of medical cannabis, which is just waiting to be released, to enter Germany. All the different producers who have felt this sudden demand have naturally gotten their act together, and sent their products to Germany, to cover the enormous demand that suddenly arose because the subsidy fund for flower medicine slammed shut with a huge bang. We have seen the first wave of patients, who normally would have received prescriptions for flower medicine, received a prescription for cannabis oils instead. I hope that next week, the batch of Weeco Astrum10/10 that is waiting to be released will actually be released and come onto the shelves, so that the oil is ready when the next wave comes and needs cannabis oil. The above is only speculation on my part.
- ·3 päivää sitten · MuokattuStock status Everything is status quo, so we can conclude that it has not yet been possible to get the oil into Germany. But as long as Germany is not completely dry, people can get hold of the oil when they get a prescription. The following is on my bill. I'm crossing my fingers that Weeco Pharma will manage to get the oil into Germany before the people who have hoarded a small stock of flower medicine privately run out. The people who hoarded this summer have been able to buy 100 grams per month. Around 200 grams in total. How long will it take them to smoke/vape 200 grams of cannabis 2-3 months? As these stocks run out, they will go to their doctor to get a prescription for an alternative cannabis medicine to the flower medicine. Weeco Astrum 10/10 is not affected by a 6-month quarantine, and the product has retained 100% reimbursement, and therefore doctors can calmly (the feared Regress system) prescribe Weeco Astrum 10/10 to patients where doctors assess that they should have a prescription for Weeco Astrum 10/10. If my little unscientific calculation is correct, Weeco Pharma has a couple of months to run on, so I guess they will make it. It says approximately in the middle of the article and under the heading How exactly is cannabis prescribed? https://www.aerzteblatt.de/archiv/medizinisches-cannabis-die-wichtigsten-aenderungen-8947932a-bc22-401b-a928-ee432de6bc59I just have an addition to the above. It occurred to me that I have read somewhere that it was also changed that people now have to meet with their general practitioner to get a prescription for medical cannabis. Telemedicine is forbidden (if I have understood it correctly, it is a complicated topic) A maximum of (at most) 3 months may pass before a doctor sees their patient with a chronic illness, which again means that the doctor may at most prescribe a prescription for medical cannabis that lasts for 3 months. Previously, they could prescribe a prescription for Weeco Astrum 10/10 2 bottles of 30 ml. and people typically bought 2 bottles at a time. They can no longer do that, when one bottle typically lasts 2-3 months. https://www.hausaerztlichepraxis.digital/praxis/medikamente-fuer-mehrere-monate-auf-rezept-moeglich-127970.html
- ·12.8.stock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.Today's figures increase in number of trades 612% the price 0.932 kr. and the price has increased by 3.72%.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt





